Immunotherapy: THE BTLA-HVEM AXIS IS A CRUCIAL IMMUNE CHECKPOINT OF T CELL IMMUNOTHERAPIES FOR CANCER

Autor:	P. Guruprasad, A. Carturan, Y. Zhang, G. Ghilardi, K. Kumashie, K. Kim, Y. Lee, J. Kim, J. Lee, M. Shestov, R. Pajarillo, J. Harris, Y.G. Lee, M. Wang, A. Joshi, H. Ballard, I. Cohen, O. Ugwuanyi, A. Hong, L. Paruzzo, R. Patel, O. Shestova, P. Porazzi, J. Svoboda, M. Ruella
Rok vydání:	2023
Předmět:	Cancer Research Transplantation Oncology Immunology Immunology and Allergy Cell Biology Genetics (clinical)
Zdroj:	Cytotherapy. 25:S226-S227
ISSN:	1465-3249
DOI:	10.1016/s1465-3249(23)00575-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::71db9d1350120b6389b0409dc1af918b https://doi.org/10.1016/s1465-3249(23)00575-3 Zobrazit plný text záznamu Full Text from ScienceDirect